125 related articles for article (PubMed ID: 20373145)
1. Analysis of mismatch repair gene mutations in Turkish HNPCC patients.
Tunca B; Pedroni M; Cecener G; Egeli U; Borsi E; Zorluoglu A; Di Gregorio C; Yilmazlar T; Yerci O; de Leon MP
Fam Cancer; 2010 Sep; 9(3):365-76. PubMed ID: 20373145
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation.
Yang SR; Gedvilaite E; Ptashkin R; Chang J; Ziegler J; Mata DA; Villafania LB; Nafa K; Hechtman JF; Benayed R; Zehir A; Benhamida J; Arcila ME; Mandelker D; Rudin CM; Paik PK; Drilon A; Schoenfeld AJ; Ladanyi M
J Thorac Oncol; 2024 Mar; 19(3):409-424. PubMed ID: 37838086
[TBL] [Abstract][Full Text] [Related]
3. Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.
Kadiyska TK; Kaneva RP; Nedin DG; Alexandrova AB; Gegova AT; Lalchev SG; Christova T; Mitev VI; Horst J; Bogdanova N; Kremensky IM
World J Gastroenterol; 2006 Dec; 12(48):7848-51. PubMed ID: 17203532
[TBL] [Abstract][Full Text] [Related]
4. Lynch syndrome from a surgeon perspective: retrospective study of clinical impact of mismatch repair protein expression analysis in colorectal cancer patients less than 50 years old.
Baiocchi GL; Portolani N; Vermi W; Baronchelli C; Gheza F; Zogno C; Scaglia A; Marchina E; Tiberio GA; Giulini SM
BMC Surg; 2014 Feb; 14():9. PubMed ID: 24533633
[TBL] [Abstract][Full Text] [Related]
5. BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.
Deihimi S; Lev A; Slifker M; Shagisultanova E; Xu Q; Jung K; Vijayvergia N; Ross EA; Xiu J; Swensen J; Gatalica Z; Andrake M; Dunbrack RL; El-Deiry WS
Oncotarget; 2017 Jun; 8(25):39945-39962. PubMed ID: 28591715
[TBL] [Abstract][Full Text] [Related]
6. Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors.
Kim H; Lim KY; Park JW; Kang J; Won JK; Lee K; Shim Y; Park CK; Kim SK; Choi SH; Kim TM; Yun H; Park SH
Lab Invest; 2022 Feb; 102(2):160-171. PubMed ID: 34848827
[TBL] [Abstract][Full Text] [Related]
7. Rare single-nucleotide variants of MLH1 and MSH2 genes in patients with Lynch syndrome.
Mirabdolhosseini SM; Yaghoob Taleghani M; Rejali L; Sadeghi H; Fatemi N; Tavallaei M; Famil Meyari A; Saeidi N; Ketabi Moghadam P; Sadeghi A; Asadzadeh Aghdaei H; Zali MR; Nazemalhosseini Mojarad E
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1930. PubMed ID: 37919876
[TBL] [Abstract][Full Text] [Related]
8. [Lynch syndrome: case report and review of the literature].
Bouguenouch L; Samri I; Belhassan K; Sayel H; Abbassi M; Bennis S; Benajah DA; Ibrahimi A; Amarti A; Ouldim K
Pan Afr Med J; 2016; 24():142. PubMed ID: 27642480
[TBL] [Abstract][Full Text] [Related]
9. A "Two-in-One Hit" Model of Shortcut Carcinogenesis in MLH1 Lynch Syndrome Carriers.
Ahadova A; Stenzinger A; Seppälä T; Hüneburg R; Kloor M; Bläker H;
Gastroenterology; 2023 Jul; 165(1):267-270.e4. PubMed ID: 36907525
[No Abstract] [Full Text] [Related]
10. Rapid development of colorectal neoplasia in patients with Lynch syndrome.
Edelstein DL; Axilbund J; Baxter M; Hylind LM; Romans K; Griffin CA; Cruz-Correa M; Giardiello FM
Clin Gastroenterol Hepatol; 2011 Apr; 9(4):340-3. PubMed ID: 21070872
[TBL] [Abstract][Full Text] [Related]
11. Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate.
Schweizer MT; Cheng HH; Tretiakova MS; Vakar-Lopez F; Klemfuss N; Konnick EQ; Mostaghel EA; Nelson PS; Yu EY; Montgomery B; True LD; Pritchard CC
Oncotarget; 2016 Dec; 7(50):82504-82510. PubMed ID: 27756888
[TBL] [Abstract][Full Text] [Related]
12. Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.
Lindor NM
Surg Oncol Clin N Am; 2009 Oct; 18(4):637-45. PubMed ID: 19793571
[TBL] [Abstract][Full Text] [Related]
13. MLH1 Loss in Primary Prostate Cancer.
Nourmohammadi Abadchi S; Sena LA; Antonarakis ES; Pritchard CC; Eshleman JR; Konnick EQ; Salipante SJ; Shenderov E; Lotan TL
JCO Precis Oncol; 2023 May; 7():e2200611. PubMed ID: 37196219
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibition rescues clinically significant unstable variants of the mismatch repair protein Msh2.
Arlow T; Scott K; Wagenseller A; Gammie A
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):246-51. PubMed ID: 23248292
[TBL] [Abstract][Full Text] [Related]
15. A 39 kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing.
Bjørnstad PM; Aaløkken R; Åsheim J; Sundaram AYM; Felde CN; Østby GH; Dalland M; Sjursen W; Carrizosa C; Vigeland MD; Sorte HS; Sheng Y; Ariansen SL; Grindedal EM; Gilfillan GD
Eur J Hum Genet; 2024 May; 32(5):513-520. PubMed ID: 38030917
[TBL] [Abstract][Full Text] [Related]
16. MSH2 Loss in Primary Prostate Cancer.
Guedes LB; Antonarakis ES; Schweizer MT; Mirkheshti N; Almutairi F; Park JC; Glavaris S; Hicks J; Eisenberger MA; De Marzo AM; Epstein JI; Isaacs WB; Eshleman JR; Pritchard CC; Lotan TL
Clin Cancer Res; 2017 Nov; 23(22):6863-6874. PubMed ID: 28790115
[No Abstract] [Full Text] [Related]
17. Surviving without BRCA2: MLH1 gets R-looped in to curtail genomic instability.
Johnson N
J Clin Invest; 2024 Apr; 134(7):. PubMed ID: 38557488
[TBL] [Abstract][Full Text] [Related]
18. Classification of MLH1 Missense VUS Using Protein Structure-Based Deep Learning-Ramachandran Plot-Molecular Dynamics Simulations Method.
Tam B; Qin Z; Zhao B; Sinha S; Lei CL; Wang SM
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255924
[TBL] [Abstract][Full Text] [Related]
19. A review of statistical methods for testing genetic anticipation: looking for an answer in Lynch syndrome.
Boonstra PS; Gruber SB; Raymond VM; Huang SC; Timshel S; Nilbert M; Mukherjee B
Genet Epidemiol; 2010 Nov; 34(7):756-68. PubMed ID: 20878717
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1.
Harley I; Rosen B; Risch HA; Siminovitch K; Beiner ME; McLaughlin J; Sun P; Narod SA
Gynecol Oncol; 2008 Jun; 109(3):384-7. PubMed ID: 18405947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]